An Integrated Approach to the Pharmacological Therapy of

All of the major scientific respiratory societies have defined chronic obstructive pulmonary disease (COPD) as a disease state characterized by airflow limitation that is not fully reversible [1-3]. The Global Initiative for Lung Disease (GOLD) has expanded the concept to include that airflow limitation is usually progressive and associated with an abnormal inflammatory response to inhaled particles or gases [1].